Company intelligence / Profile preview

Horus Pharma

Nice, Provence-Alpes-Côte d'Azur, Francehorus-pharma.com ↗

Ownership: Private
Development stage: Other

Overview

Horus Pharma is a leading independent French pharmaceutical company specializing in preservative-free ophthalmology products, with a portfolio of 60+ innovative solutions including prescription medicines, medical devices, and food supplements. The company has European marketing authorizations for its drugs and distributes its products in over 30 countries. Its lead product includes fluocinolone acetonide for diabetic macular oedema, which has reached the NDA/BLA stage.

Therapeutic areas: Ophthalmology
Modalities: Small moleculeMedical deviceFood supplement (nutraceuticals)
Industry: Biotech

Drug pipeline

1 asset

DM934

Unknown

Partnerships

Distribution agreements with partners in Romania, Portugal, Croatia, Turkey, Algeria, Qatar, Ireland and Bosnia; total of at least nineteen distribution collaborations worldwide.

Beyond the preview

Go deeper on Horus Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Horus Pharma.